Skip to search formSkip to main contentSkip to account menu

HSV-1 HF10

Known as: HF10, HSV1 HF10, Herpes Simplex Virus Type 1 HF10 
A non-engineered, naturally oncolytic, replication-competent spontaneous herpes simplex virus (HSV) type I mutant variant. Upon intratumoral… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Results from phase I study of the oncolytic viral immunotherapy agent canerpaturev (C-REV) in combination with gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer.
325 Background: Canerpaturev (C-REV, formerly HF10) is an oncolytic, spontaneous mutant Herpes Simplex Virus type 1, and is one… 
2017
2017
MicroRNAs in muscle wasting and cachexia induced by heart failure
Review
2016
Review
2016
Response: A Systematic Evaluation of Burst Spinal Cord Stimulation for Chronic Back and Limb Pain
Background Traditional tonic spinal cord stimulation (SCS) has been approved by FDA for chronic pain of intractable back and… 
2012
2012
Conductive Gluing as Interconnection Technique towards Solar Cells without Front Busbars and Rear Pads
The focus of this work was set on studying the reliability of solar modules with cells interconnected by means of conductive… 
2010
2010
Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Highly Cited
2008
Highly Cited
2008
Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Review
2007
Review
2007
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.
We reviewed our clinical trial using mutant herpes simplex virus "HF10". We have evaluated the safety and effect of HF10 against… 
2006
2006
Pilot Study of Oncolytic Viral Therapy Using Mutant Herpes Simplex Virus (HF10) Against Recurrent Metastatic Breast Cancer
BackgroundAn oncolytic herpes simplex virus type 1 mutant (HF10) has been isolated and evaluated for antitumor efficacy in a… 
2003
2003
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses.
BACKGROUND/AIMS Oncolytic herpes simplex virus type 1 mutants are promising therapeutic agents for malignant tumors. Their… 
1986
1986
Comparison of media used for human in vitro fertilization and embryo transfer programs--a new method of serum preparation.
Two-cell ICR-mouse embryos were cultured to compare media used for human in vitro fertilization and embryo transfer (IVF-ET… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)